A new research indicates that people from socioeconomic groups benefit from low-dose CT screening for lung cancer survival. Professor Stephen Duffy from the Wolfson Institute of Population Health and colleagues from the…
Category: Lung Cancer News
FDA Grants Approval to Amgen’s Treatment for deadly form of Lung Cancer
Every year, about 35k Americans are diagnosed with small cell lung cancer and the cancer usually has spread beyong the lung by the time it gets detected. The Food and Drug Administration…
Understanding TIL Therapy for Lung Cancer
Lung cancer is the leading cause of cancer related deaths all around the world. Although there are various advanced treatment options and several approaches, the survival rate remains low. Here, in this…
Roche’s Genentech Gets FDA Approval for Lung Cancer Treatment
Genetech, a member of the Roche Group, had announced that U.S. Food and Drug Administration (FDA) has approved Alecensa (alectinib) for adjuvant treatment of patients with early stage, anaplastiv lymphoma kinase-positive non-small…
Lung Cancer Rates Not Declining With Reduced Smoking
In Sweden, the number of people who smoke has decreased very sharply but the number of lung cancer cases in the population is not decreasing as much as expected. In fact, lung…
ICMR Set To Bring In Evidence Based Guidelines To Conduct Meta-Analyses
The Indian Council of Medical Research (ICMR) is all set to launch a systematic review and meta-analyses to help in decision making for management of lung cancer to guide clinical practice and…
New Deep Learning Tool To Predict Brain Metastasis In Lung Cancer Patients
Lung cancer is the leading cause of deaths from cancers worldwide. Most lung cancers are characterized as non-small cell lung cancer and about 30% of patients progress to advanced stages when it…
Lung Cancer Rates Increasing Among Asian American Non-Smoking Women
Lung cancer is a rising concern among men and women all around the world. In the recent times, it has been found that lung cancer rates are dropping for every group except…